Data updated: Mar 10, 2026
APRACLONIDINE HYDROCHLORIDE
APRACLONIDINE HYDROCHLORIDE
Ophthalmology
Approved 2009-03-12
1
Indication
--
Phase 3 Trials
16
Years on Market
Details
- Status
- Prescription
- First Approved
- 2009-03-12
- Routes
- OPHTHALMIC
- Dosage Forms
- SOLUTION/DROPS
APRACLONIDINE HYDROCHLORIDE Approval History
Loading approval history...
What APRACLONIDINE HYDROCHLORIDE Treats
1 FDA approvalsOriginally approved for its first indication in 2009 .
- Other (1)
Other
(1 approval)- • Approved indication (Mar 2009)Letter
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
APRACLONIDINE HYDROCHLORIDE FDA Label Details
ProIndications & Usage
IOPIDINE 1% Ophthalmic Solution is indicated to control or prevent post-surgical elevations in IOP that occur in patients after argon laser trabeculoplasty, argon laser iridotomy or Nd:YAG posterior capsulotomy.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.